Jonathan Aschoff
Stock Analyst at Roth MKM
(0.59)
# 2,954
Out of 4,479 analysts
45
Total ratings
20%
Success rate
-29.94%
Average return
Main Sectors:
26 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BRTX BioRestorative Therapies | Maintains: Buy | $15 | $1.92 | +681.25% | 3 | Jun 12, 2024 | |
| CYCC Cyclacel Pharmaceuticals | Maintains: Buy | $21 → $11 | $1.66 | +562.65% | 2 | May 3, 2024 | |
| MBRX Moleculin Biotech | Maintains: Buy | $40 | $3.57 | +1,020.45% | 2 | Apr 12, 2024 | |
| CLRB Cellectar Biosciences | Maintains: Buy | $20 → $28 | $2.38 | +1,076.47% | 3 | Mar 28, 2024 | |
| TFFP TFF Pharmaceuticals | Maintains: Buy | $56 → $44 | $1.78 | +2,371.91% | 1 | Mar 28, 2024 | |
| BPTH Bio-Path Holdings | Maintains: Buy | $12 → $40 | $1.86 | +2,050.54% | 2 | Mar 27, 2024 | |
| PBLA Panbela Therapeutics | Maintains: Buy | $25 | $0.35 | +7,000.26% | 4 | Mar 27, 2024 | |
| MNMD Mind Medicine (MindMed) | Maintains: Buy | $25 → $36 | $6.96 | +417.24% | 1 | Mar 7, 2024 | |
| HSDT Helius Medical Technologies | Maintains: Buy | $5 → $24 | $0.97 | +2,387.05% | 2 | Mar 5, 2024 | |
| TENX Tenax Therapeutics | Reiterates: Buy | $30 | $3.17 | +846.37% | 3 | Feb 20, 2024 | |
| OTRK Ontrak | Initiates: Buy | $4 | $0.20 | +1,861.75% | 1 | Dec 5, 2023 | |
| ZVRA Zevra Therapeutics | Reiterates: Buy | $25 | $4.36 | +473.39% | 1 | Oct 6, 2023 | |
| CLNN Clene | Reiterates: Buy | $10 | $0.33 | +2,921.15% | 1 | Aug 29, 2023 | |
| IMMX Immix Biopharma | Reiterates: Buy | $14 | $1.96 | +614.29% | 2 | Aug 14, 2023 | |
| REVB Revelation Biosciences | Maintains: Buy | $150 → $450 | $1.79 | +25,039.66% | 2 | Feb 14, 2023 | |
| OCGN Ocugen | Reinstates: Buy | $8 | $1.61 | +396.89% | 1 | Jun 15, 2022 | |
| CELZ Creative Medical Technology Holdings | Initiates: Buy | $100 | $3.69 | +2,610.03% | 1 | Feb 25, 2022 | |
| BFRI Biofrontera | Initiates: Buy | n/a | $0.84 | - | 1 | Nov 24, 2021 | |
| SEEL Seelos Therapeutics | Upgrades: Buy | $600 → $1,920 | $0.59 | +325,378.89% | 2 | Sep 27, 2021 | |
| APVO Aptevo Therapeutics | Maintains: Buy | $2,816 → $2,200 | $0.30 | +738,155.03% | 2 | May 28, 2021 | |
| SHLS Shoals Technologies Group | Initiates: Buy | n/a | $6.00 | - | 1 | Mar 11, 2021 | |
| APDN Applied DNA Sciences | Initiates: Buy | $480 | $0.44 | +108,966.12% | 1 | Feb 12, 2021 | |
| INO Inovio Pharmaceuticals | Downgrades: Sell | $96 | $8.43 | +1,038.79% | 3 | Nov 17, 2020 | |
| ARDS Aridis Pharmaceuticals | Initiates: Buy | n/a | $0.06 | - | 1 | Feb 19, 2020 | |
| AMPE Ampio Pharmaceuticals | Initiates: Buy | n/a | $0.10 | - | 1 | Dec 19, 2019 | |
| INMB INmune Bio | Initiates: Buy | n/a | $8.07 | - | 1 | Dec 19, 2019 |
BioRestorative Therapies
Jun 12, 2024
Maintains: Buy
Price Target: $15
Current: $1.92
Upside: +681.25%
Cyclacel Pharmaceuticals
May 3, 2024
Maintains: Buy
Price Target: $21 → $11
Current: $1.66
Upside: +562.65%
Moleculin Biotech
Apr 12, 2024
Maintains: Buy
Price Target: $40
Current: $3.57
Upside: +1,020.45%
Cellectar Biosciences
Mar 28, 2024
Maintains: Buy
Price Target: $20 → $28
Current: $2.38
Upside: +1,076.47%
TFF Pharmaceuticals
Mar 28, 2024
Maintains: Buy
Price Target: $56 → $44
Current: $1.78
Upside: +2,371.91%
Bio-Path Holdings
Mar 27, 2024
Maintains: Buy
Price Target: $12 → $40
Current: $1.86
Upside: +2,050.54%
Panbela Therapeutics
Mar 27, 2024
Maintains: Buy
Price Target: $25
Current: $0.35
Upside: +7,000.26%
Mind Medicine (MindMed)
Mar 7, 2024
Maintains: Buy
Price Target: $25 → $36
Current: $6.96
Upside: +417.24%
Helius Medical Technologies
Mar 5, 2024
Maintains: Buy
Price Target: $5 → $24
Current: $0.97
Upside: +2,387.05%
Tenax Therapeutics
Feb 20, 2024
Reiterates: Buy
Price Target: $30
Current: $3.17
Upside: +846.37%
Ontrak
Dec 5, 2023
Initiates: Buy
Price Target: $4
Current: $0.20
Upside: +1,861.75%
Zevra Therapeutics
Oct 6, 2023
Reiterates: Buy
Price Target: $25
Current: $4.36
Upside: +473.39%
Clene
Aug 29, 2023
Reiterates: Buy
Price Target: $10
Current: $0.33
Upside: +2,921.15%
Immix Biopharma
Aug 14, 2023
Reiterates: Buy
Price Target: $14
Current: $1.96
Upside: +614.29%
Revelation Biosciences
Feb 14, 2023
Maintains: Buy
Price Target: $150 → $450
Current: $1.79
Upside: +25,039.66%
Ocugen
Jun 15, 2022
Reinstates: Buy
Price Target: $8
Current: $1.61
Upside: +396.89%
Creative Medical Technology Holdings
Feb 25, 2022
Initiates: Buy
Price Target: $100
Current: $3.69
Upside: +2,610.03%
Biofrontera
Nov 24, 2021
Initiates: Buy
Price Target: n/a
Current: $0.84
Upside: -
Seelos Therapeutics
Sep 27, 2021
Upgrades: Buy
Price Target: $600 → $1,920
Current: $0.59
Upside: +325,378.89%
Aptevo Therapeutics
May 28, 2021
Maintains: Buy
Price Target: $2,816 → $2,200
Current: $0.30
Upside: +738,155.03%
Shoals Technologies Group
Mar 11, 2021
Initiates: Buy
Price Target: n/a
Current: $6.00
Upside: -
Applied DNA Sciences
Feb 12, 2021
Initiates: Buy
Price Target: $480
Current: $0.44
Upside: +108,966.12%
Inovio Pharmaceuticals
Nov 17, 2020
Downgrades: Sell
Price Target: $96
Current: $8.43
Upside: +1,038.79%
Aridis Pharmaceuticals
Feb 19, 2020
Initiates: Buy
Price Target: n/a
Current: $0.06
Upside: -
Ampio Pharmaceuticals
Dec 19, 2019
Initiates: Buy
Price Target: n/a
Current: $0.10
Upside: -
INmune Bio
Dec 19, 2019
Initiates: Buy
Price Target: n/a
Current: $8.07
Upside: -